共 109 条
[1]
Wakabayashi T(2008)Intravitreal bevacizumab to treat iris neovascularization and neovascular glaucoma secondary to ischemic retinal diseases in 41 consecutive cases Ophthalmology 115 1571-80
[2]
Oshima Y(2013)Anti-vascular endothelial growth factor for neovascular glaucoma Cochrane Database Syst Rev 10 CD007920-72
[3]
Sakaguchi H(2013)Recent advances in the management of neovascular glaucoma Semin Ophthalmol 28 165-11
[4]
Ikuno Y(2005)Neovascular glaucoma Folia Med (Plovdiv) 47 5-7
[5]
Miki A(2012)Anti-VEGF therapy for the treatment of glaucoma: a focus on ranibizumab and bevacizumab Expert Opin Biol Ther 12 1641-91
[6]
Gomi F(2012)Current approaches in neovascular glaucoma Zhonghua Yan Ke Za Zhi 48 488-33
[7]
Otori Y(2014)The link between intravitreal antivascular endothelial growth factor injections and glaucoma Curr Opin Ophthalmol 25 127-74
[8]
Kamei M(2012)Clinical and electrophysiologic outcome in patients with neovascular glaucoma treated with and without bevacizumab Eur J Ophthalmol 22 563-9
[9]
Kusaka S(2013)Levels of erythropoietin and vascular endothelial growth factor in surgery-required advanced neovascular glaucoma eyes before and after intravitreal injection of bevacizumab Invest Ophthalmol Vis Sci 54 3874-7
[10]
Tano Y(2013)Adjunctive with versus without intravitreal bevacizumab injection before Ahmed glaucoma valve implantation in the treatment of neovascular glaucoma Chin Med J (Engl) 126 1412-73